Ikarian Capital LLC 13D and 13G filings for TRACON Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-05 4:10 pm Sale |
2024-03-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 133,547 5.900% |
-4,730 (-3.42%) |
Filing |
| 2023-02-14 12:57 pm Purchase |
2022-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 138,277 12.500% |
3,721 (+2.77%) |
Filing |
| 2022-02-14 4:37 pm Sale |
2021-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 134,556 13.800% |
-1,287 (-0.95%) |
Filing |
| 2021-02-16 08:33 am Purchase |
2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 135,842 17.800% |
27,715 (+25.63%) |
Filing |
| 2020-09-14 5:00 pm Purchase |
2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 108,127 16.400% |
108,127 (New Position) |
Filing |